Ads
related to: breast cancer cell lines- Treatment Option
Learn About An Rx Treatment Option
For Metastatic Breast Cancer.
- Tips On Living With mBC
Tips On Coping, Motherhood,
Relationships & Nutrition
- Metastatic Breast Cancer
Visit For Info On A Metastatic
Breast Cancer Rx Treatment Option.
- Patient Resources
Visit For Patient Resources On A
Metastatic Breast Cancer Rx Option.
- Doctor Discussion Guide
Find A Discussion Guide To Aid
In Talking With Your Doctor
- Savings Information
Learn How To Save On A Metastatic
Breast Cancer Rx Treatment Option.
- Treatment Option
Search results
Seattle researchers explore causes of ovarian cancer: HealthLink
KING5 Seattle· 6 days agoMedical researchers in Washington state are looking deeper into what causes ovarian cancer, thanks...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
“Cell therapies change the definition of human”
Hardwood Paroxysm· 5 days agoThe researcher recently visited Barcelona to present his latest book, Cell harmony (debate) at the Institute of Bioengineering of Catalonia (IBEC), where...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 15 hours agoFurther, sales of breast cancer drug Verzenio and diabetes med Jardiance came up short. But Zepbound...
BostonGene Immune Profiling Platform Shows Promise in Predicting Cancer Immunotherapy Benefit
GenomeWeb News· 6 days agoThe firm and its scientific collaborators detailed the development, training, and initial validation of the platform this month in Cancer Cell, noting that ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 4 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
Clinical Trials Arena via Yahoo Finance· 4 days ago"AstraZeneca and Daiichi Sankyo’s ADC...
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 3 days agoThe FDA accepted an application for Dato-Dxd as a treatment for non-squamous non-small cell lung ...
Galvanize Therapeutics' endoscopic, pulsed-field needle scores FDA clearance in cancer, soft tissue...
FierceBiotech· 2 days agoAccording to Galvanize—which billed its forthcoming system as the first commercial product to...
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of...
Nature· 4 days agoRNA in situ hybridization (RNA-ISH) and quantitative reverse transcription PCR (qRT-PCR) were used to estimate hsa_circ_0007590 expression in PDAC clinical specimens and cell